Saga Stories in Health Talks in Primary Child Healthcare

April 3, 2024 updated by: Marie Löf, docent, Karolinska Institutet

An Effectiveness-implementation Hybrid Trial to Evaluate a Health Promotion Intervention Within Swedish Primary Child Healthcare: Saga Stories in Health Talks

Primary child healthcare in Sweden is an important arena for health promotion interventions as nurses regularly meet parents and children from birth to five years of age. To date there is a lack of evidence-based material for child healthcare nurses to use in health promotion talks within primary child healthcare. Therefore, the aims of this study are to: (i) evaluate the effectiveness of Saga Stories in health talks on parental self-efficacy to promote healthy diet, physical activity, and screen time behaviours in 5-year-old children and (ii) evaluate the implementation of Saga Stories in health talks with regards to acceptability, appropriateness, feasibility, fidelity, adoption, sustainability, satisfaction, and usage.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

763

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Huddinge, Sweden, 141 83
        • Department of Biosciences and Nutrition, Karolinska Institutet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 5 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The parent the accompanies the child to the 5-year check-up at primary child healthcare needs to be able to understand Swedish sufficiently well in order to provide informed consent and partake in the Saga Stories health talk.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Receives the Saga Stories health promotion talk as well as take-home material
Saga Stories in health talks consists of material for child healthcare nurses to use to facilitate the health talk with both the child and parent(s) and is complemented with take-home material. Every nurse will receive a large flip-chart with colourful pictures and text to facilitate their health talk at the 5-year check-up. The flip-chart will include information and questions regarding food, physical activity and sedentary behaviour, sleep, dental health, as well as bathroom habits. At the conclusion of the check-up the children will receive the book 'Saga Stories: Your amazing body and brain´ as well as games for the child to take home to promote healthy lifestyle behaviours (fruit and vegetable bingo and a physical activity fortune teller).
No Intervention: Control
Receives standard health promotion talk

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-efficacy
Time Frame: At the end of the intervention which is two months after baseline
Parental self-efficacy for promoting healthy dietary and physical activity behaviours in their children´ questionnaire
At the end of the intervention which is two months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intake of key dietary indicators as assessed by a questionnaire
Time Frame: At the end of the intervention which is two months after baseline
Intake of fruits, vegetables, and sugar sweetened drinks (grams/day)
At the end of the intervention which is two months after baseline
Screen time as assessed by a questionnaire
Time Frame: At the end of the intervention which is two months after baseline
Number of minutes per day spent in front of a screen
At the end of the intervention which is two months after baseline
Acceptability
Time Frame: 3 months after implementation
Acceptability of the Saga Stories intervention by the child healthcare nurses (assessed by the questionnaire by Weiner et al.) It includes four questions assessed on a five point likert scale ranging from completely disagree to completely agree.
3 months after implementation
Appropriateness
Time Frame: 3 months after implementation
Appropriateness of the Saga Stories intervention by the child healthcare nurses (assessed by the questionnaire by Weiner et al.) It includes four questions rated on a five point likert scale ranging from completely disagree to completely agree.
3 months after implementation
Feasibility of implementing Saga Stories
Time Frame: 3 months after implementation
Feasibility of the Saga Stories intervention by the child healthcare nurses (assessed with by questionnaire by Weiner et al.) It includes four questions rated on a five point likert scale ranging from completely disagree to completely agree.
3 months after implementation
Change in the fidelity of the Saga Stories intervention
Time Frame: 2, 4, 6, 8, 10, and 12 months after implementation
Assessment based on checklist developed for this study (0, not implemented and 1, implemented)
2, 4, 6, 8, 10, and 12 months after implementation
Change in the adoption of the Saga Stories intervention
Time Frame: 2, 4, 6, 8, 10, and 12 months after implementation
Assessment based on checklist developed for this study (0, not implemented and 1, implemented)
2, 4, 6, 8, 10, and 12 months after implementation
Sustainability
Time Frame: One year after implementation
Semi-structured interviews with primary child healthcare nurses
One year after implementation
Parental satisfaction and usage of Saga Stories
Time Frame: Post-intervention (i.e., 2 months after baseline assessment)
Questionnaire
Post-intervention (i.e., 2 months after baseline assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2022

Primary Completion (Actual)

December 1, 2022

Study Completion (Actual)

January 31, 2023

Study Registration Dates

First Submitted

January 21, 2022

First Submitted That Met QC Criteria

February 2, 2022

First Posted (Actual)

February 14, 2022

Study Record Updates

Last Update Posted (Actual)

April 4, 2024

Last Update Submitted That Met QC Criteria

April 3, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-06106-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self Efficacy

Clinical Trials on Saga Stories

Subscribe